ES2880796T3 - Fluido terapéutico peritoneal - Google Patents
Fluido terapéutico peritoneal Download PDFInfo
- Publication number
- ES2880796T3 ES2880796T3 ES16739518T ES16739518T ES2880796T3 ES 2880796 T3 ES2880796 T3 ES 2880796T3 ES 16739518 T ES16739518 T ES 16739518T ES 16739518 T ES16739518 T ES 16739518T ES 2880796 T3 ES2880796 T3 ES 2880796T3
- Authority
- ES
- Spain
- Prior art keywords
- peritoneal
- therapeutic fluid
- use according
- compound
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HBAPIWQLIRHVCF-UHFFFAOYSA-N CCCCC(C(C1O)O)[O](C)C(CO)C1O Chemical compound CCCCC(C(C1O)O)[O](C)C(CO)C1O HBAPIWQLIRHVCF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0021—Special media to be introduced, removed or treated removed from and reintroduced into the body, e.g. after treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15177544.2A EP3120842A1 (en) | 2015-07-20 | 2015-07-20 | Peritoneal therapeutic fluid |
| PCT/EP2016/067186 WO2017013120A1 (en) | 2015-07-20 | 2016-07-19 | Peritoneal therapeutic fluid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2880796T3 true ES2880796T3 (es) | 2021-11-25 |
Family
ID=53785450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16739518T Active ES2880796T3 (es) | 2015-07-20 | 2016-07-19 | Fluido terapéutico peritoneal |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20180221303A1 (enExample) |
| EP (2) | EP3120842A1 (enExample) |
| JP (1) | JP6448847B2 (enExample) |
| KR (2) | KR102266889B1 (enExample) |
| CN (2) | CN107921009B (enExample) |
| AU (1) | AU2016296216B2 (enExample) |
| BR (1) | BR112018001005B1 (enExample) |
| CA (1) | CA2990532C (enExample) |
| CO (1) | CO2018000236A2 (enExample) |
| CY (1) | CY1124467T1 (enExample) |
| DK (1) | DK3324951T3 (enExample) |
| ES (1) | ES2880796T3 (enExample) |
| HR (1) | HRP20211319T1 (enExample) |
| HU (1) | HUE055208T2 (enExample) |
| LT (1) | LT3324951T (enExample) |
| MX (1) | MX387020B (enExample) |
| PL (1) | PL3324951T3 (enExample) |
| PT (1) | PT3324951T (enExample) |
| RS (1) | RS62142B1 (enExample) |
| RU (1) | RU2718908C2 (enExample) |
| SI (1) | SI3324951T1 (enExample) |
| SM (1) | SMT202100428T1 (enExample) |
| WO (1) | WO2017013120A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3381484A1 (en) | 2017-03-31 | 2018-10-03 | Opterion Health AG | Carbohydrate composition for dialysis |
| CN108310005A (zh) * | 2018-04-18 | 2018-07-24 | 浙江天瑞药业有限公司 | 一种抗腹膜纤维化的腹膜透析液 |
| WO2020081654A1 (en) * | 2018-10-16 | 2020-04-23 | President And Fellows Of Harvard College | Sirt1 activating compounds |
| WO2025265015A1 (en) * | 2024-06-20 | 2025-12-26 | Barinta Therapeutics, Inc. | Flavylium cations and electrolyte complexes thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2155910C (en) * | 1995-08-11 | 1999-12-14 | George Wu | Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis |
| MXPA02001472A (es) * | 1999-08-10 | 2002-07-02 | Ml Lab Plc | Metodo para suministrar agentes terapeuticos utilizando una solucion de dextrina. |
| WO2001028544A2 (en) | 1999-10-15 | 2001-04-26 | The Dow Chemical Company | Dialysis solution including polyglycol osmotic agent |
| JP4882054B2 (ja) * | 2000-09-13 | 2012-02-22 | 独立行政法人科学技術振興機構 | 腹膜透析液およびその調製法 |
| WO2003024391A2 (en) * | 2001-08-16 | 2003-03-27 | Mucosal Therapeutics, Inc. | Treatment and prevention of mucositis in cancer patients |
| GB0200704D0 (en) * | 2002-01-14 | 2002-02-27 | Britannia Pharmaceuticals Ltd | Use of phospholipids in peritoneal dialysis |
| ITRM20020562A1 (it) * | 2002-11-06 | 2004-05-07 | Sigma Tau Ind Farmaceuti | Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza. |
| SE524530C2 (sv) * | 2002-12-10 | 2004-08-24 | Gambro Lundia Ab | Metod för att framställa en medicinsk lösning för peritonealdialys där en lösning innehållandes ett eller flera acetylerade eller deacetylerade aminosocker värme- eller strålningssteriliseras med bestämda pH-värden och med bestämda viktsprocent för att undvika att cytotoxiska produkter bildas. |
| WO2005049049A1 (en) * | 2003-11-17 | 2005-06-02 | Braintree Laboratories, Inc. | Therapeutic peg solution concentrate |
| US7498341B2 (en) | 2004-01-31 | 2009-03-03 | Sanofi Aventis Deutschland Gmbh | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
| US7384558B2 (en) | 2004-07-26 | 2008-06-10 | Baxter International Inc. | Compositions capable of inhibiting reactive oxygen and carbonyl species |
| US20060292099A1 (en) * | 2005-05-25 | 2006-12-28 | Michael Milburn | Treatment of eye disorders with sirtuin modulators |
| WO2007049796A2 (en) | 2005-10-26 | 2007-05-03 | Kao Corporation | Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver |
| US20090035240A1 (en) * | 2007-07-31 | 2009-02-05 | Maes Daniel H | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent |
| JP2010535221A (ja) * | 2007-07-31 | 2010-11-18 | イーエルシー マネージメント エルエルシー | レスベラトロール誘導体を含有する化粧用組成物 |
| US20110281957A1 (en) * | 2008-11-26 | 2011-11-17 | Lipoprotein Technologies, Inc. | Enhanced bioactive formulations of resveratrol |
| JP5778584B2 (ja) * | 2009-01-19 | 2015-09-16 | ライコード・リミテツド | カロテノイドとポリフェノールとの相乗的組み合わせ |
| US8637569B2 (en) | 2009-10-22 | 2014-01-28 | Api Genesis, Llc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| ES2365429B1 (es) * | 2010-03-05 | 2012-09-06 | Universidad De Castilla De La Mancha | Solucion para dialisis peritoneal |
| EP2609918A1 (en) * | 2011-12-27 | 2013-07-03 | Zytoprotec GmbH | Peritoneal dialysis fluid comprising a GSK-3 inhibitor |
| US9919004B2 (en) * | 2012-04-24 | 2018-03-20 | The University Of British Columbia | Polymer-based dialysate |
| EP2695606A1 (en) * | 2012-08-09 | 2014-02-12 | ETH Zürich | Liposome composition for peritoneal dialysis |
| ITRM20130135A1 (it) * | 2013-03-06 | 2014-09-07 | Michele Azzolini | Nuovi derivati del resveratrolo. |
| CN103330715B (zh) * | 2013-07-01 | 2015-09-02 | 华仁药业股份有限公司 | 一种抗腹膜纤维化的腹膜透析液 |
-
2015
- 2015-07-20 EP EP15177544.2A patent/EP3120842A1/en not_active Withdrawn
-
2016
- 2016-07-19 BR BR112018001005-7A patent/BR112018001005B1/pt active IP Right Grant
- 2016-07-19 RU RU2018106122A patent/RU2718908C2/ru active
- 2016-07-19 SI SI201631288T patent/SI3324951T1/sl unknown
- 2016-07-19 PL PL16739518T patent/PL3324951T3/pl unknown
- 2016-07-19 RS RS20210925A patent/RS62142B1/sr unknown
- 2016-07-19 CA CA2990532A patent/CA2990532C/en active Active
- 2016-07-19 CN CN201680042681.5A patent/CN107921009B/zh active Active
- 2016-07-19 WO PCT/EP2016/067186 patent/WO2017013120A1/en not_active Ceased
- 2016-07-19 US US15/745,903 patent/US20180221303A1/en not_active Abandoned
- 2016-07-19 KR KR1020197006327A patent/KR102266889B1/ko active Active
- 2016-07-19 HR HRP20211319TT patent/HRP20211319T1/hr unknown
- 2016-07-19 MX MX2018000336A patent/MX387020B/es unknown
- 2016-07-19 JP JP2018503533A patent/JP6448847B2/ja active Active
- 2016-07-19 AU AU2016296216A patent/AU2016296216B2/en active Active
- 2016-07-19 KR KR1020187001830A patent/KR20180048577A/ko not_active Ceased
- 2016-07-19 ES ES16739518T patent/ES2880796T3/es active Active
- 2016-07-19 HU HUE16739518A patent/HUE055208T2/hu unknown
- 2016-07-19 PT PT167395185T patent/PT3324951T/pt unknown
- 2016-07-19 DK DK16739518.5T patent/DK3324951T3/da active
- 2016-07-19 SM SM20210428T patent/SMT202100428T1/it unknown
- 2016-07-19 EP EP16739518.5A patent/EP3324951B1/en active Active
- 2016-07-19 CN CN201910196687.3A patent/CN110075307A/zh active Pending
- 2016-07-19 LT LTEP16739518.5T patent/LT3324951T/lt unknown
-
2018
- 2018-01-12 CO CONC2018/0000236A patent/CO2018000236A2/es unknown
-
2019
- 2019-09-27 US US16/586,113 patent/US11160766B2/en active Active
-
2021
- 2021-08-13 CY CY20211100731T patent/CY1124467T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11160766B2 (en) | Peritoneal therapeutic fluid | |
| ES2370478T3 (es) | Carbohidratos antiadhesivos. | |
| US11185514B2 (en) | Aqueous solution comprising a polyphenol | |
| ES2691872T3 (es) | Aminofucoidan como un vector para la fibrinolisis en enfermedades trombóticas | |
| HK40011489A (en) | Peritoneal therapeutic fluid | |
| HK1251176B (en) | Peritoneal therapeutic fluid | |
| JPWO2017082121A1 (ja) | 徐放性局所投与剤 | |
| ES2636646B1 (es) | NUEVOS VEHÍCULOS PARA LA TRANSFECCIÓN DE miRNAs | |
| KR20160044493A (ko) | 전이 형성 및/또는 재발을 예방하는 데 사용하기 위한 다당류 | |
| HK1254524B (en) | Aqueous solution comprising a stilbenoid | |
| BR112019020586A2 (pt) | composição, método para produzir uma composição aquosa líquida e recipiente ou kit | |
| BR112017027350B1 (pt) | Método para aumentar a solubilidade de estilbenoide, solução aquosa e seu uso e uso de alfa-glucano de redução |